Jul 28, 2026
Remdesivir treatment reduces cardiovascular complications in kidney transplant recipients with COVID-19
Study finds that kidney transplant recipients treated with remdesivir within a week of COVID-19 diagnosis and receiving at least three consecutive days of therapy experienced fewer cardiovascular complications compared to those who did not receive the antiviral treatment.
1 source
00